In this April 2025 issue of Annals of Thoracic Surgery (JCR Q1, IF: 3.6), a retrospective study, led by Professors Jianxing He and Shuben Li from the ...

Sleeve lobectomy is used in a small proportion of nonsmall-cell lung cancer (NSCLC) patients, but a new study suggests that it might have a bigger role to play.

A recent study suggests that sleeve lobectomy is safe to perform in patients with non–small cell lung cancer who received neoadjuvant therapy. In patients with non­–small-cell lung cancer ...

"Initially, the sleeve lobectomy was introduced for patients with lung cancer who were unable to tolerate a full pneumonectomy," stated the study's lead investigator, Yong Soo Choi, MD.

In seven of the true positive cases the frozen section led to an extended surgical operation (additional lobectomy or bronchial sleeve resection performed), resulting in an ultimate negative margin.

If the proximal portion of the bronchus is involved by direct extension of the tumor or if there is lymph node metastasis at the hilum and neither lobectomy nor pneumonectomy could ensure that the ...

Non-small-cell lung cancer develops when normal cells mutate and begin to divide and grow rapidly in lung tissue. Once diagnosed, your doctor will see how far it has spread to determine the amount ...

Patients were split between the 823,746 who received surgery prior to the COVID-19 pandemic (January 2016 through December 2019) and the 164,690 patients who had surgery during the pandemic ...